Recombinant Human IGLON5 Protein: Research Use Guide
Recombinant Human IGLON5 Protein: Research Use Guide
Recombinant Human IGLON5 Protein is a cell adhesion molecule belonging to the IgLON subfamily of the immunoglobulin superfamily, increasingly studied for its role in neurological disorders including IGLON5-related tauopathy and autoimmune encephalopathy.
- Product Name
- Recombinant Human IGLON5 Protein
- SKU
- rp368300
- Protein Family
- IgLON subfamily, Immunoglobulin Superfamily
- Primary Research Area
- Neuroscience, autoimmune encephalopathy, cell adhesion
- Recommended Storage
- Store at -80°C; avoid repeated freeze-thaw cycles
- Typical Applications
- ELISA, Western blot, cell-based assays, antibody production
Protein Background and Biological Significance
IGLON5 (IgLON Family Member 5) is a glycosylphosphatidylinositol (GPI)-anchored cell adhesion molecule expressed predominantly in the central nervous system. It belongs to the IgLON subfamily within the broader immunoglobulin superfamily and shares structural features including multiple immunoglobulin-like C2-type domains that mediate homophilic and heterophilic cell–cell interactions.
IGLON5 has attracted significant clinical and research interest following the discovery of anti-IGLON5 autoantibodies in patients presenting with a distinctive syndrome characterized by non-REM and REM sleep parasomnias, bulbar dysfunction, and an underlying tauopathy. This condition, now recognized as IGLON5-related tauopathy (or anti-IGLON5 disease), underscores the protein's importance at the intersection of autoimmunity and neurodegeneration.
Beyond autoimmune contexts, IGLON5 is studied for its roles in axon guidance, synapse formation, and neural circuit development, making Recombinant Human IGLON5 Protein a valuable tool for dissecting these pathways in vitro.
Reconstitution, Handling, and Storage Protocol
Reconstitution: If supplied in lyophilized form, briefly centrifuge the vial before opening to pellet any protein that may have adhered to the cap or sides. Reconstitute in sterile, deionized water or an appropriate buffer (e.g., PBS, pH 7.4) to a concentration of 0.1–1.0 mg/mL. Allow the solution to equilibrate at room temperature for 10–15 minutes with gentle swirling; do not vortex, as this may cause aggregation or denaturation.
Handling precautions: Use low-protein-binding microcentrifuge tubes and pipette tips to minimize adsorption losses. If carrier protein is required for low-concentration working solutions, supplement with 0.1–0.5% BSA (molecular biology grade).
Storage: Aliquot reconstituted protein into single-use volumes to avoid repeated freeze-thaw cycles, which degrade activity. Store aliquots at -80°C for long-term preservation (up to 12 months) or at -20°C for short-term use (up to 1 month). Once thawed, keep on ice and use within the same working session. Do not refreeze.
Note: Always consult the product-specific datasheet provided with SKU rp368300 for lot-specific reconstitution volumes and concentration recommendations.
Recommended Applications and Experimental Considerations
ELISA: Recombinant Human IGLON5 Protein is suitable as a coating antigen or standard for enzyme-linked immunosorbent assays aimed at detecting and quantifying anti-IGLON5 antibodies in serum or cerebrospinal fluid samples. Optimize coating concentrations (typically 1–4 µg/mL) and blocking conditions empirically for your platform.
Western Blot: The recombinant protein can serve as a positive control to confirm antibody specificity in Western blot experiments. Load 50–200 ng per lane alongside cell lysate samples for comparative analysis.
Cell-Based Functional Assays: IGLON5 mediates cell adhesion and neurite outgrowth. Recombinant protein can be adsorbed onto culture substrates or presented in solution to study its effects on neuronal morphology, adhesion, and signaling in primary neuron or neuroblastoma cell cultures.
Antibody Production and Validation: The protein is appropriate for immunization protocols to generate research-grade anti-IGLON5 antibodies, as well as for antibody affinity purification and validation.
General tip: Include appropriate positive and negative controls in every assay. Verify the biological activity of each new lot using a functional assay prior to committing to large-scale experiments.
Quality Control and Purity Considerations
Recombinant proteins intended for research applications should meet defined quality benchmarks. When evaluating Recombinant Human IGLON5 Protein (rp368300), consider the following quality parameters:
- Purity: SDS-PAGE and/or HPLC analysis should confirm purity. Confirm the expected molecular weight band for IGLON5, taking into account any glycosylation that may shift apparent molecular weight on denaturing gels.
- Endotoxin levels: For cell-based assays, endotoxin contamination can confound results. Request the endotoxin specification from the Certificate of Analysis (CoA) and verify it is within acceptable limits for your application (typically <1 EU/µg for sensitive cell assays).
- Biological activity: Where a functional assay is established (e.g., cell adhesion assay), confirm activity on receipt of each lot.
- Protein identity: Mass spectrometry or N-terminal sequencing data on the CoA can confirm identity. Review the CoA provided by Aladdin Scientific for lot-specific data.
Always request the Certificate of Analysis for lot rp368300 before use, and archive it with your experimental records for traceability and regulatory compliance.
Frequently asked questions
What expression system is used to produce Recombinant Human IGLON5 Protein (rp368300)?
The specific expression system (e.g., HEK293, CHO, E. coli, or baculovirus) used for rp368300 should be confirmed by consulting the product datasheet or Certificate of Analysis available from Aladdin Scientific. The expression system is critical as it determines post-translational modifications such as glycosylation, which can affect IGLON5 folding and functional activity.
How should I handle Recombinant Human IGLON5 Protein to maintain its activity?
To maintain protein activity, reconstitute gently without vortexing, aliquot into single-use volumes immediately after reconstitution, and store at -80°C for long-term use. Avoid repeated freeze-thaw cycles, use low-protein-binding consumables, and keep the protein on ice during experimental setup. Adding a carrier protein such as 0.1% BSA may stabilize the protein at low working concentrations.
Is Recombinant Human IGLON5 Protein suitable for use as an ELISA standard for detecting anti-IGLON5 antibodies?
Yes, Recombinant Human IGLON5 Protein is commonly used as a coating antigen or calibration standard in ELISA platforms for detecting anti-IGLON5 autoantibodies in patient samples. Optimal coating concentrations and blocking conditions should be determined empirically for your specific assay format and detection antibody pair.
What is the clinical relevance of IGLON5, and why is it important for neuroscience research?
Anti-IGLON5 autoantibodies have been identified in patients with a rare autoimmune neurological syndrome featuring sleep disorders, bulbar symptoms, and tau pathology, now termed IGLON5-related tauopathy. Research into IGLON5 helps elucidate mechanisms underlying autoimmune neurodegeneration, synaptic function, and cell adhesion in the nervous system, making recombinant IGLON5 protein an important research reagent in these fields.
Can Recombinant Human IGLON5 Protein be used in cell-based neurite outgrowth assays?
IGLON5, as a member of the IgLON family of cell adhesion molecules, has been implicated in neurite outgrowth and axon guidance based on the known biology of the IgLON subfamily. Recombinant Human IGLON5 Protein may therefore be applicable in substrate-coating or solution-phase neurite outgrowth assays using primary neurons or neuronal cell lines; however, researchers should validate conditions empirically and consult current literature for optimized protocols.
References
- Gaig C, et al. Anti-IGLON5 disease. Handbook of Clinical Neurology. 2021. A review of the clinical, pathological, and immunological features of IGLON5-related tauopathy.
- Sabater L, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurology. 2014.
- Hortsch M, Margolis B. (Eds.) The Protein Kinases. Textbook-level reference on immunoglobulin superfamily cell adhesion molecules including IgLON subfamily domain structure and function.
- Aladdin Scientific. Product datasheet: Recombinant Human IGLON5 Protein, SKU rp368300. Aladdin Scientific internal document.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)